Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

NCT02537431 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

X-linked Hypophosphatemia

Interventions

BIOLOGICAL: burosumab

Sponsor

Kyowa Kirin, Inc.

Collaborators

[object Object]